• 🌎 Worldwide
    • πŸ‡ΊπŸ‡Έ U.S.
    • πŸ‡¨πŸ‡¦ Canada
    • πŸ‡¬πŸ‡§ United Kingdom
    • 🌏 Asia
    • 🌍 Europe
    • 🌎 Latin America
    • 🌏 Oceania and Australasia
The Daily Marijuana Observer
SUBSCRIBE
  • Home
  • Latest
  • Business
  • Investments
  • Law
  • People
  • Health
  • Databases
No Result
View All Result
The Daily Marijuana Observer
  • Home
  • Latest
  • Business
  • Investments
  • Law
  • People
  • Health
  • Databases
No Result
View All Result
The Daily Marijuana Observer
No Result
View All Result
Home PRO

PRO: Roth Capital Initiates Coverage on InMed Pharmaceuticals with a Buy Rating

Steven Lachard by Steven Lachard
March 20, 2019
in Analyst Action, Canada, Investments, Marijuana Stocks, PRO, Trading
TMX Group Limited InMed Pharmaceuticals Inc- Opens the Market - Cannabis Stocks

InMed Pharmaceuticals Inc. Opens the Market (CNW Group/TMX Group Limited)

173
SHARES
ShareShare

In a recently released analyst research report, Roth Capital Partnersβ€˜ Managing Director and Senior Research Analyst, Jerry Isaacson, Ph.D., just initiated coverage on shares of pre-clinical stage cannabinoid biopharmaceutical company InMed Pharmaceuticals Inc. (TSX:IN) (OTC:IMLFF) with a buy rating and a lofty price target.

Jerry Isaacson’s initial price target of $1.10 CAD per share implies a potential upside of approximately 83.33% based on the last traded price of $0.60 CAD per share of IN on the Toronto Stock Exchange, a.k.a. TSX.

This initiation of coverage comes just days after the company provided ashareholder update regardingits drug development program for the treatment of Epidermolysis Bullosa.

Why Isaacson is Bullish on InMed Pharma

According to TheFly, “Roth Capital analyst Jerry Isaacson started InMed Pharmaceuticals with a Buy rating and C$1.10 price target. The company is developing a bacterial platform for the biosynthesis of medically relevant cannabinoids as well as a portfolio of cannibinoid treatments for diseases with “high unmet medical need,” Isaacson tells investors in a research note. He believes InMed’s platform has the potential to deliver some natural cannabinoids in cost-effective quantities for clinical and commercial development.”

Be sure toΒ subscribe to updates here so you never miss an important development.

Share this:

  • Click to email this to a friend (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Reddit (Opens in new window)
  • Click to share on Telegram (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to share on Pinterest (Opens in new window)
  • Click to share on Tumblr (Opens in new window)
  • Click to share on Pocket (Opens in new window)
Tags: biotechInMed Pharmaceuticals Inc.Jerry IsaacsonOTC:IMLFFROTH Capital Partners LLCTSX:IN

Get Real-Time Updates from MJobserver.com

Unsubscribe
Steven Lachard

Steven Lachard

Steven Lachard is a staff writer for MJobserver.com with a particular focus on marijuana stocks. Beyond MJobserver.com, Steven's pot stock insights have been featured on TalkMarkets.com and more.

Related Posts

Epidiolex from GW Pharmaceuticals
Investments

Jazz Pharmaceuticals to Acquire GW Pharmaceuticals plc, Creating an Innovative, High-Growth, Global Biopharma Leader

February 3, 2021
Epidiolex from GW Pharmaceuticals
Investments

Greenwich Biosciences, Inc., a Subsidiary of GW Pharmaceuticals plc, Launches unspoken symphony, a Breakthrough Innovation Created for the US Epilepsy Community

October 21, 2020
Epidiolex from GW Pharmaceuticals
Executives

GW Pharmaceuticals Announces the Appointment of David Gryska to its Board of Directors

September 10, 2020
Marinol Dronabinol THC Pharmaceutical
Events

30+ Expert Speakers to Present at the 3rd Annual Cannabinoid-Derived Pharmaceuticals Summit

July 9, 2020
Cannabis Clinical Trials
Health

Drug Trial Planned For Synthetic Cannabinoid COVID-19 Treatment

June 8, 2020
Cannabis News - Marijuana Becomes Legal in Michigan Starting December 6th
Press Releases

GW Pharmaceuticals to Host Virtual Investor Event on Its Nabiximols U.S. Development Program and Market Opportunity

June 4, 2020
Load More
Next Post
Marijuana Stocks - Losers

5 of Today’s Biggest Marijuana Stock Losers - Wednesday, March 20, 2019

Leave a Comment! Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

🚨 Subscribe to Stock Alerts

Get Live Updates on Breaking News

Subscribe Now

βœ‰οΈ Subscribe to Our Newsletter!

* indicates required

πŸ”Ž Search Marijuana Stocks

πŸ“° Recent News

  • Aleafia Health Launches Everyday Cannabis Brand Divvy
  • Green Thumb Industries Expands Independent Governance with Appointment of Swati Mylavarapu to Board of Directors
  • Healixa Inc. Appoints Kealy Altman as Vice President of Marketing
  • MediPharm Labs Achieves Export Milestone, Ships Cannabis Oil from Australia to Germany
  • Verano Holdings Shares Approved to Trade on OTC Markets Under the Symbol VRNOF
Facebook Twitter Instagram LinkedIn Youtube

Cannabis News by Region

  • πŸ‡ΊπŸ‡Έ United States
  • πŸ‡¨πŸ‡¦ Canada
  • πŸ‡¬πŸ‡§ United Kingdom
  • 🌏 Asia
  • 🌍 Europe
  • 🌎 Latin America
  • 🌏 Oceania and Australasia

Cannabis Tools & Resources

  • πŸ“… Calendar
  • πŸ“Š Databases
  • πŸ“‡ Directories
  • πŸ”” RSS Feeds
  • πŸ“Ί Videos

Find Cannabis Business Services

  • βš–οΈ Attorneys & Law Firms
  • πŸ“Š Accountants & Accounting Firms
  • πŸ’‘ Consultants & Consulting Firms
  • πŸ“² Marketing Agencies & Firms

The Daily Marijuana Observer

  • Subscribe
  • About MJobserver.com
  • Affiliate Marketing Disclosure
  • Legal Disclaimer
  • Privacy Policy
  • Contact Us

Advertise with Us

  • πŸ‘€ Advertise
  • πŸ“£ DMO Newswire
  • πŸ“‡ List in Our Databases

Β© 2018 - 2021 D.M.O. Holdings Corp.
DISCLAIMER: DMO Holdings Corp., which owns The Daily Marijuana Observerβ„’ (MJobserver.com), is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. DMO Holdings Corp., which owns MJobserver.com, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. DMO Holdings Corp. or its affiliates, which owns MJobserver.com, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two.

No Result
View All Result
  • Home
  • Latest
  • πŸ”’ PRO
    • πŸ”’ A.M. Watchlist
    • πŸ”’ Analyst Action
  • πŸ’Ό Business
  • πŸ“ˆ Investments
    • πŸ“ˆ Stocks
    • πŸ’° ETFs and Funds
    • πŸ’­ Market Commentary
    • πŸ“° Press Releases
    • πŸ“… Earnings Calendar
  • βš–οΈ Law
    • Laws
    • Politics
    • Intellectual Property
    • Attorneys & Law Firms Database
  • πŸ‘₯ People
    • ⚽ Athletes
    • πŸ’Ό Executives
    • 🌟 Celebrities
    • πŸ›’ Consumers
    • βš•οΈ Doctors
    • πŸ’Š Patients
  • πŸ’Š Health
  • πŸ“‡ Databases
    • πŸ“ˆ Stock Databases
    • πŸ’° Fund Databases
    • πŸ’Ό Service Providers Databases
    • 🏦 Marijuana Stock Brokers
    • πŸ’² Marijuana Cryptocurrencies

Β© 2018 - 2021 D.M.O. Holdings Corp.
DISCLAIMER: DMO Holdings Corp., which owns The Daily Marijuana Observerβ„’ (MJobserver.com), is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. DMO Holdings Corp., which owns MJobserver.com, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. DMO Holdings Corp. or its affiliates, which owns MJobserver.com, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two.

Login to your account below

Forgotten Password? Sign Up

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.